Plus   Neg

CompuGroup Medical Cuts FY EBITDA Outlook

CompuGroup Medical said it cut its EBITDA guidance for fiscal year 2019 due to one-off costs for abandoned major M&A transaction.

The company now expects EBITDA for the full year 2019 to be in the range of 175 million euros to 190 million euros taking into account the M&A transaction costs, compared to previously expected 190 million euros to 205 million euros excluding M&A transaction costs.

But, the company still expects annual revenues to be in the range of 720 million euros to 750 million euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT